Sophora flavescens Aiton inhibits the production of pro-inflammatory cytokines through inhibition of the NF κB/IκB signal pathway in human mast cell line (HMC-1)

被引:48
作者
Hong, Myung Hee [1 ,2 ]
Lee, Ji Young [3 ]
Jung, Hee [1 ,2 ]
Jin, Dong-Hoon [4 ]
Go, Ho Yeon
Kim, Ji Hye [1 ,2 ]
Jang, Bo-Hyoung [1 ,2 ]
Shin, Yong-Cheol [1 ,2 ]
Ko, Seong-Gyu [1 ,2 ]
机构
[1] Kyung Hee Univ, Coll Oriental Med, Lab Clin Biol & Pharmacogen, Seoul 130701, South Korea
[2] Kyung Hee Univ, Inst Oriental Med, Seoul 130701, South Korea
[3] Dongguk Univ, Dept Sasang Constitut Med, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Med Res Ctr, Dept Anat & Tumor Immun, Seoul 151, South Korea
关键词
Allergic inflammation; HMC-1; NF kappa B; Pro-inflammatory cytokine; Sophora flavescens Aiton; TUMOR-NECROSIS-FACTOR; PASSIVE CUTANEOUS ANAPHYLAXIS; GENE-EXPRESSION; TNF-ALPHA; HISTAMINE-RELEASE; PROTEIN-KINASE; MOUSE SKIN; IN-VITRO; ACTIVATION; INTERLEUKIN-8;
D O I
10.1016/j.tiv.2008.12.002
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The dried roots of Sophora flavescens Aiton (SFA) has been used in traditional medicine for treatment of inflammation, gastrointestinal hemorrhage, diarrhea, and asthma. In the present study, we investigated the effect of SFA on the inflammatory allergic reaction using human mast cell-1 (HMC-1). SFA (200 mg/kg) inhibited the mast cell-mediated passive cutaneous anaphylaxis reaction in vivo and the release of histamine from rat peritoneal mast cells by compound 48/80. In addition, the expression levels of phorbol 12-myristate 13-acetate (PMA) and calcium ionophore A23187-stimulated TNF-alpha, IL-6, and IL-8 were also decreased by SFA treatment. In molecular mechanism level, this study showed that SFA inhibited the nuclear translocation of nuclear factor (NF) kappa B through inhibition of the phosphorylation and degradation of IKB-alpha, which is an inhibitor of NF kappa B. Moreover, SFA suppressed PMA plus A23187-induced phosphorylation of the mitogen-activated protein kinase p38 and c-jun N-terminal kinase. The inhibited induction of NF kappa B promoter by SFA was determined using luciferase activity. These results suggest that SFA could be used as a treatment for mast cell-derived allergic inflammatory diseases. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:251 / 258
页数:8
相关论文
共 45 条
[1]  
Ahn DK., 1998, ILLUSTRATED BOOK KOR, P199
[2]   Mitogen-activated protein kinases [J].
Arbabi, S ;
Maier, RV .
CRITICAL CARE MEDICINE, 2002, 30 (01) :S74-S79
[3]   Substance P induces TNF-α and IL-6 production through NFκB in peritoneal mast cells [J].
Azzolina, A ;
Bongiovanni, A ;
Lampiasi, N .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1643 (1-3) :75-83
[4]   I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR [J].
BAEUERLE, PA ;
BALTIMORE, D .
SCIENCE, 1988, 242 (4878) :540-546
[5]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[6]   Matrine improves 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice [J].
Cheng, H ;
Xia, B ;
Zhang, L ;
Zhou, F ;
Zhang, YX ;
Ye, M ;
Hu, ZG ;
Li, J ;
Li, J ;
Wang, ZL ;
Li, C ;
Guo, QS .
PHARMACOLOGICAL RESEARCH, 2006, 53 (03) :202-208
[7]   NF-κB:: pivotal mediator or innocent bystander in atherogenesis? [J].
Collins, T ;
Cybulsky, MI .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :255-264
[8]   INHIBITION OF HISTAMINE-RELEASE INDUCED BY COMPOUND 48-80 AND PEPTIDE-401 IN THE PRESENCE AND ABSENCE OF CALCIUM - IMPLICATIONS FOR THE MODE OF ACTION OF ANTI-ALLERGIC COMPOUNDS [J].
ENNIS, M ;
ATKINSON, G ;
PEARCE, FL .
AGENTS AND ACTIONS, 1980, 10 (03) :222-228
[9]   Mast cells as "tunable" effector and immunoregulatory cells: Recent advances [J].
Galli, SJ ;
Kalesnikoff, J ;
Grimbaldeston, MA ;
Piliponsky, AM ;
Williams, CMM ;
Tsai, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :749-786
[10]   PURIFICATION OF RAT CUTANEOUS MAST-CELLS WITH PERCOLL DENSITY CENTRIFUGATION [J].
HACHISUKA, H ;
KUSUHARA, M ;
HIGUCHI, M ;
OKUBO, K ;
SASAI, Y .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1988, 280 (06) :358-362